D Medical Industries Ltd. (DMEDF) Financials Nov 10, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for D Medical Industries Ltd.
Fiscal year is January-December. All values ILS millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 368,000 1.26M 1.51M 918,000 0
Cost of Goods Sold (COGS) incl. D&A 1.03M 9.59M 11M 4.07M 10,000
COGS excluding D&A 642,000 8.93M 9.81M 3.13M 0
Depreciation & Amortization Expense 392,000 662,000 1.19M 932,000 10,000
Depreciation 343,000 520,000 - - -
Amortization of Intangibles 49,000 142,000 - - -
Gross Income (666,000) (8.32M) (9.49M) (3.15M) (10,000)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 19.08M 27.92M 30.79M 10.56M 2.02M
Research & Development 12.83M 13.76M 14.81M 2.53M -
Other SG&A 6.25M 14.16M 15.98M 8.03M 2.02M
Other Operating Expense 500,000 0 0 0 0
Unusual Expense 0 2.47M 7.48M 5.27M (1.41M)
EBIT after Unusual Expense 0 (2.47M) (7.48M) (5.27M) 1.41M
Non Operating Income/Expense 1.14M (7.46M) (392,000) 4.74M 440,000
Non-Operating Interest Income 87,000 282,000 7,000 61,000 2,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 100,000 - 54,000
Gross Interest Expense 0 0 100,000 - 54,000
Interest Capitalized 0 0 0 0 0
Pretax Income (19.02M) (45.89M) (48.24M) (14.17M) (234,000)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - 0 0
Income Tax - Current Foreign 0 0 - 0 0
Income Tax - Deferred Domestic 0 0 - 0 0
Income Tax - Deferred Foreign 0 0 - 0 0
Income Tax Credits 0 0 - 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income (19.02M) (45.89M) (48.24M) (14.17M) (234,000)
Minority Interest Expense (580,000) (3.17M) (1.04M) 0 0
Net Income (18.44M) (42.73M) (47.2M) (14.17M) (234,000)
Extraordinaries & Discontinued Operations 0 0 2.4M 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 3.62M 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 (1.22M) 0 0
Net Income After Extraordinaries (18.44M) (42.73M) (44.8M) (14.17M) (234,000)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (18.44M) (42.73M) (47.2M) (14.17M) (234,000)
EPS (Basic) (24.35) (64.90) (61.86) (12.30) (0.16)
Basic Shares Outstanding 757,227 658,200 782,700 1.15M 1.51M
EPS (Diluted) (24.35) (64.90) (61.86) (12.30) (0.16)
Diluted Shares Outstanding 757,227 658,200 782,700 1.15M 1.51M
EBITDA (19.85M) (35.59M) (39.09M) (12.77M) (2.02M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for D Medical Industries Ltd.
Fiscal year is January-December. All values ILS millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 368,000 1.26M 1.51M 918,000 0
Cost of Goods Sold (COGS) incl. D&A 1.03M 9.59M 11M 4.07M 10,000
COGS excluding D&A 642,000 8.93M 9.81M 3.13M 0
Depreciation & Amortization Expense 392,000 662,000 1.19M 932,000 10,000
Depreciation 343,000 520,000 - - -
Amortization of Intangibles 49,000 142,000 - - -
Gross Income (666,000) (8.32M) (9.49M) (3.15M) (10,000)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 19.08M 27.92M 30.79M 10.56M 2.02M
Research & Development 12.83M 13.76M 14.81M 2.53M -
Other SG&A 6.25M 14.16M 15.98M 8.03M 2.02M
Other Operating Expense 500,000 0 0 0 0
Unusual Expense 0 2.47M 7.48M 5.27M (1.41M)
EBIT after Unusual Expense 0 (2.47M) (7.48M) (5.27M) 1.41M
Non Operating Income/Expense 1.14M (7.46M) (392,000) 4.74M 440,000
Non-Operating Interest Income 87,000 282,000 7,000 61,000 2,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 100,000 - 54,000
Gross Interest Expense 0 0 100,000 - 54,000
Interest Capitalized 0 0 0 0 0
Pretax Income (19.02M) (45.89M) (48.24M) (14.17M) (234,000)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - 0 0
Income Tax - Current Foreign 0 0 - 0 0
Income Tax - Deferred Domestic 0 0 - 0 0
Income Tax - Deferred Foreign 0 0 - 0 0
Income Tax Credits 0 0 - 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income (19.02M) (45.89M) (48.24M) (14.17M) (234,000)
Minority Interest Expense (580,000) (3.17M) (1.04M) 0 0
Net Income (18.44M) (42.73M) (47.2M) (14.17M) (234,000)
Extraordinaries & Discontinued Operations 0 0 2.4M 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 3.62M 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 (1.22M) 0 0
Net Income After Extraordinaries (18.44M) (42.73M) (44.8M) (14.17M) (234,000)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (18.44M) (42.73M) (47.2M) (14.17M) (234,000)
EPS (Basic) (24.35) (64.90) (61.86) (12.30) (0.16)
Basic Shares Outstanding 757,227 658,200 782,700 1.15M 1.51M
EPS (Diluted) (24.35) (64.90) (61.86) (12.30) (0.16)
Diluted Shares Outstanding 757,227 658,200 782,700 1.15M 1.51M
EBITDA (19.85M) (35.59M) (39.09M) (12.77M) (2.02M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
